BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
Clinical trial NCT02246439 · COMPLETED
Trial details
- NCT number
- NCT02246439
- Sponsor
- RedHill Biopharma Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-08
- Primary completion
- 2017-02-13
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.